Canadian CANNAINVESTOR Magazine October 2018 | Página 25

Some

perspective:

Think of how insulin is created globally - the drug that is naturally created by our body but also scientifically created for people with conditions such as diabetes. Perhaps you know of someone or are personally affected by this yourself.

Personally speaking, I knew the daily ins and outs of my grandmother taking insulin in order to properly

sustain herself. The process that Hyasynth is undergoing with their patent-pending strains of yeast is very similar in nature to what was discovered with insulin and yeast so long ago.

What does this look like recreationally?

Now obviously, there will always be a demand for premium high-quality indoor flower, and Organigram is certainly not going away from their roots in that regard. Where Hyasynth kicks in for the recreational market is in the 2nd wave of legalization to come within a year after the October 17th, 2018 legalization date. Cannabinoids are extracted to produce products such as vape pens, edibles, beverages, topicals, tinctures, etc, etc and what better way to produce these products at a sustainable cost than to produce pure cannabinoids in 1-2 weeks instead of 12-20.

25